While HHT is inherently a bleeding disorder, patients are at a higher risk of venous thromboembolism (VTE) and stroke, which is particularly due to high levels of factor VIII and von Willebrand factor (vWF). This evidence concerns the gene VWF and hemorrhagic disease.